Filing Details
- Accession Number:
- 0001127602-14-014834
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-18 19:58:17
- Reporting Period:
- 2014-04-17
- Filing Date:
- 2014-04-18
- Accepted Time:
- 2014-04-18 19:58:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-04-17 | 3,833 | $34.56 | 3,973 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-04-17 | 3,833 | $99.59 | 140 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-04-17 | 5,233 | $30.75 | 5,373 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-04-17 | 2,933 | $96.93 | 2,440 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-04-17 | 1,100 | $98.10 | 1,340 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-04-17 | 1,000 | $98.93 | 340 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-04-17 | 200 | $99.76 | 140 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2014-04-17 | 3,833 | $0.00 | 3,833 | $34.56 |
Common Stock | Stock Options | Disposition | 2014-04-17 | 5,233 | $0.00 | 5,233 | $30.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
337,330 | 2005-12-30 | 2015-12-30 | No | 4 | M | Direct |
737,836 | 2009-12-26 | 2017-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 166 | Indirect | By Spouse |
Common Stock | 533,094 | Indirect | By Trusts |
Footnotes
- This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- This transaction was executed in multiple trades at prices ranging from $98.7301 to $99.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $96.58 to $97.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $97.58 to $98.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $98.72 to $99.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $99.73 to $99.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.